Searchable abstracts of presentations at key conferences in endocrinology

ea0026p488 | Thyroid cancer | ECE2011

Radiodine therapy and age at menopause in women with differentiated thyroid cancer

Martins T , Azevedo T , Martinho M , Oliveira S , Neto J , Rodrigues F

Introduction: Radiodine (131I) is widely used in the treatment of patients with thyroid cancer. This therapy is associated with some adverse effects including possible impairment of ovarian function and earlier menopause.Objective: The aim of this study was to evaluate female fertility after treatment with 131I of differentiated thyroid cancer (DTC).Methods: We retrospectively analysed 250 women with DTC treat...

ea0090p325 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Insulin resistance and hyperglycemia induce mitochondrial dysfunction and a metabolic towards use of gluconeogenic amino acids in epithelial kidney cells

Braga Patricia , Bernardino Raquel , Guerra-Carvalho Barbara , Carrageta David F. , Rodrigues Anabela , Oliveira Pedro F. , Alves Marco

Diabetic nephropathy (DN) and insulin resistance (IR) in kidney cells are considered the main cause of end-stage renal failure. Additionally, hyperglycemia and increased fatty (FA) acids are observed in patients with type 2 diabetes mellitus, where lipid accumulation has been correlated to IR. Nonetheless, the impact of IR in early disease stages is still unclear. Moreover, proximal renal tubular cells have high mitochondrial content where aerobic respiration is their primary ...

ea0026p484 | Thyroid cancer | ECE2011

Seventh UICC/TNM staging criteria for medullary thyroid carcinoma: is there any prognostic advantage?

Martinho M , Azevedo T , Carrilho F , Martins T , Ribeiro C , Melo M , Cunha N , Rascao M J , Neves A , Gilde P , Pires J L , Cruz C , Oliveira C , Neto J , Oliveira S , Valido F , Gomes I , Carvalheiro M , Rodrigues F

Background and aims: The value of the revised (2009) UICC/TNM criteria for medullary thyroid cancer (MTC) is not established. We aimed to evaluate its predictive value, analyzing the consequences of the inclusion of T3N0M0 patients previously included in stage III of the 6th edition, in stage II of the 7th.Patients and methods: We retrospectively analysed the clinical records of 85 patients operated for MTC and followed in two tertiary hospitals in the c...

ea0026p485 | Thyroid cancer | ECE2011

Very low-risk papillary thyroid carcinoma: where to set the limits?

Martinho M , Azevedo T , Martins T , Cunha N , Rascao M J , Oliveira C , Neto J , Oliveira S , Gilde P , Neves A , Gomes I , Cruz C , Valido F , Campos B , Rodrigues F

Currently there is no widely accepted definition of very low-risk papillary thyroid carcinoma (PTC). Although unifocal microcarcinomas without extrathyroidal extension and no local or distant metastases have been recognized as having an excellent overall prognosis the threshold for such a favourable clinical behaviour remains controversial. The study aim was to identify the clinicopathological characteristics of T1 tumours (≤2 cm) presenting a very low-risk of mortality ...